| Uniprot ID | Q14956 |
|---|---|
| Common Name | CDX-011 (DOX), CR011, glembatumumab vedotin (ADC), Unconjugated mAb |
| Conjugate | Unconjugated |
| Synonyms | HGFIN, NMB |
| Applications | ELISA, Flow Cyt |
| Recommended Dilutions | ELISA 1:5000-10000, Flow Cyt 1:100 |
| Formulation & Reconstitution | Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions. |
| Host Species | Homo sapiens |
| IgG type | Human IgG2(S378A) – Kappa |
| Reactivity | Human |
| Target | |
| Description | Anti-GPNMB(glembatumumab biosimilar) mAb |
| Delivery | In Stock |
| Storage & Shipping | Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature. |
| Background | Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals. Our unconjugated biosimilar monoclonal antibodies (mAbs) are based on the sequences outlined in relevant patents or scientific publications. These antibodies are in their native, unconjugated form, meaning they do not contain any payload or therapeutic agent attached. They are designed for use in research and development, and their performance has been tested as standalone molecules through comprehensive QC tests. |
| Usage | Research use only |
服务热线
400-006-0995
18062749453
